# A Study of Pre-operative Metformin in Prostate Cancer

> **NCT00881725** · PHASE2 · TERMINATED · sponsor: **University Health Network, Toronto** · enrollment: 24 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT00881725
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2011-03
- **Final completion:** 2012-06
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Slow Accrual
- **Last updated:** 2012-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00881725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00881725, "A Study of Pre-operative Metformin in Prostate Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00881725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*